Proto Labs Inc
Income Statement
| Line Item | FY2026 | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 |
|---|---|---|---|---|---|---|---|---|
| Revenue | — | $533.1M | $500.9M | $503.9M | $488.4M | $488.1M | $434.4M | $458.7M |
| Cost of Revenue | — | $296.0M | $277.7M | $281.9M | $272.9M | $265.4M | $216.6M | $223.4M |
| Gross Profit | — | $237.1M | $223.2M | $222.0M | $215.5M | $222.7M | $217.8M | $235.3M |
| Gross Margin | — | 44.5% | 44.6% | 44.1% | 44.1% | 45.6% | 50.1% | 51.3% |
| Operating Expenses | ||||||||
| Research & Development | — | $42.8M | $41.3M | $40.1M | $38.2M | $44.2M | $36.9M | $32.7M |
| SG&A Expense | — | $69.8M | $64.3M | $65.8M | $67.5M | $55.9M | $51.7M | $49.8M |
| Operating Income | — | $25.1M | $19.9M | $28.2M | $-98.0M | $40.3M | $59.8M | $79.9M |
| Operating Margin | — | 4.7% | 4.0% | 5.6% | -20.1% | 8.3% | 13.8% | 17.4% |
| Interest Expense | — | — | — | — | — | — | — | — |
| Pretax Income | — | $31.1M | $24.7M | $28.0M | $-97.9M | $40.2M | $62.9M | $81.2M |
| Income Tax Expense | — | $9.8M | $8.1M | $10.7M | $5.6M | $6.8M | $12.1M | $17.5M |
| Net Income | — | $21.2M | $16.6M | $17.2M | $-103.5M | $33.4M | $50.9M | $63.7M |
| Net Margin | — | 4.0% | 3.3% | 3.4% | -21.2% | 6.8% | 11.7% | 13.9% |
| EPS (Basic) | — | $0.89 | $0.66 | $0.66 | $-3.77 | $1.21 | $1.90 | $2.37 |
| EPS (Diluted) | — | $0.88 | $0.66 | $0.66 | $-3.77 | $1.21 | $1.89 | $2.35 |
| Shares Outstanding (Basic) | 23.8M | 23.9M | 25.1M | 26.2M | 27.4M | 27.6M | 26.7M | 26.9M |
| Shares Outstanding (Diluted) | 23.8M | 24.2M | 25.2M | 26.2M | 27.4M | 27.7M | 26.9M | 27.0M |
| Dividends Per Share | — | — | — | — | — | — | — | — |